Initial dose:
- 20 to 64 years
- Patients with undergoing mandibular impacted third molar tooth extraction accompanied
by lateral bone removal and crown cutting
- Patients with pain that meets both of the following criteria
- Pain intensity (4-categorical): "moderate pain" or "severe pain"
- Pain intensity (VAS): 45.0 mm or more
Additional dose:
- Patients with pain that corresponds to "4. Agree" or "5. Strongly agree" as the answer
to the "question about the pain intensity" during the period from 5 hours to 12 hours
post-initial dose of the study drug
- Patients with acute inflammatory findings in the oral cavity necessitating treatment
- Patients who are scheduled to receive general anesthesia and analgesics in the process
of the eligible tooth extraction